Future Perspectives and Challenges: Interleukins in Immune Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 15 August 2024 | Viewed by 78
Special Issue Editor
Interests: biodefence; cancer immunity; cytokine; diversity of myeloid cell; diversity of cell signaling; immunology; inflammatory disease; innate immunity; myeloid-derived suppressor cell (MDSC); neutrophils
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Through the systematic examination and analysis of the interleukins produced by immune cells, the elucidation of pathogeneses of diseases has been pursued. Currently, it has become possible to limit disease pathogenesis through the control of immune responses in various diseases, and as a strategy for immune control, the suppression of immune cell activation is being carried out through various methods.
On the other hand, new interleukin actions and producing cells have been identified, and novel subsets and plasticity have been elucidated even in known immune cells. Furthermore, issues such as the decrease in therapeutic effects due to neutralizing antibodies have become clearer and need to be addressed.
In this Special Issue, we aim to highlight the problems to be addressed in various diseases, the actions of interleukins that may provide new explanations for their pathogeneses, and the methods and possibilities for new clinical applications, thereby currently marking the starting point of budding and emerging new immunotherapies.
Specifically, we are soliciting original articles and reviews targeting diseases, immune responses, and immunotherapies such as those listed below:
- Autoimmune disease;
- Inflammatory disease;
- Inflammaging (aging, obesity, atherosclerosis, metabolism);
- Tumor immunity;
- Sepsis;
- Cytokine and receptor;Regulatory/suppressor cells;
- Novel therapy (aptamer, antibody therapeutic, genetically modified cells, cell adsorption).
Dr. Yuji Takeda
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune disease
- interleukin
- cytokine
